Last month, a group of 12 Senate Democrats proposed a framework for rebuilding the health care system. The idea was to spur ...

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.

FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.

Steve Ubl, chief executive of PhRMA, plans to step down at the end of the ‌year, after more than a decade leading the main ...

More data from the CDC: Overall, there were more than 3.6 million births in the U.S. last year. It sounds like a lot, but ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

Chatterjee is a professor of economic development, innovation, and global health economy at the University of Sussex and an ...

MAHA ELEVATE could open a federal funding pipeline to interventions that can't survive contact with a plausibility filter.

In December, Trump said he would summon health insurance execs to the White House. It doesn't seem a meeting ever happened.

The Trump administration will not be asking the Supreme Court to take up its fight to slash NIH support for research indirect ...

We can’t afford another sweeping restructuring of the food supply based on imprecise interventions and uncertain science,” ...

There's not a consistent theme among the 10 highest and lowest spending metros, which highlights the “irrationality” of U.S.